• Medientyp: Sonstige Veröffentlichung; E-Artikel
  • Titel: Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses
  • Beteiligte: Victoria, Catherine [Verfasser:in]; Schulz, Göran [Verfasser:in]; Klöhn, Mara [Verfasser:in]; Weber, Saskia [Verfasser:in]; Holicki, Cora M. [Verfasser:in]; Brüggemann, Yannick [Verfasser:in]; Becker, Miriam [Verfasser:in]; Gerold, Gisa [Verfasser:in]; Eiden, Martin [Verfasser:in]; Groschup, Martin H. [Verfasser:in]; Steinmann, Eike [Verfasser:in]; Kirschning, Andreas [Verfasser:in]
  • Erschienen: Washington, DC : ACS, 2023
  • Erschienen in: Journal of Medicinal Chemistry (formerly: Journal of Medicinal and Pharmaceutical Chemistry) 67 (2023), Nr. 1 ; Journal of Medicinal Chemistry (formerly: Journal of Medicinal and Pharmaceutical Chemistry)
  • Ausgabe: published Version
  • Sprache: Englisch
  • DOI: https://doi.org/10.15488/16517; https://doi.org/10.1021/acs.jmedchem.3c01357
  • ISSN: 0022-2623
  • Schlagwörter: Antiviral Agents ; Animals ; Hepatitis E virus ; Chikungunya Fever ; Viruses
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: The synthesis of a library of halogenated rocaglate derivatives belonging to the flavagline class of natural products, of which silvestrol is the most prominent example, is reported. Their antiviral activity and cytotoxicity profile against a wide range of pathogenic viruses, including hepatitis E, Chikungunya, Rift Valley Fever virus and SARS-CoV-2, were determined. The incorporation of halogen substituents at positions 4′, 6 and 8 was shown to have a significant effect on the antiviral activity of rocaglates, some of which even showed enhanced activity compared to CR-31-B and silvestrol.
  • Zugangsstatus: Freier Zugang